Enzon Pharmaceuticals Inc
ENZN
$0.50
+196.7% (1 year change)
$0.50
+196.7% (1 year change)
$38.5 Million
The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.$0.02 - $0.85
The lowest and highst price in the last 52 weeks.-19.04x
The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.$0.00 (0.0%)
Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).| Market Cap | $38.5 Million |
| Enterprise Value | -$9.65 Million |
| Dividend Yield | $0.00 (0.0%) |
| 1 Year Return | +196.7% |
| 52-Week High | $0.85 |
| 52-Week Low | $0.02 |
| Beta | 0.0 |
| Outstanding Shares | 74.2 Million |
| Avg 30 Day Volume | 46.7 Thousand |
| P/E Ratio | -19.04 |
| PEG | -18.21 |
| Earnings per Share | -$0.03 |
| Price to Sales Ratio | Infinity |
| Price to Book Ratio | Infinity |
| Revenue to Enterprise Value | -22.38 |
| EBIT to Enterprise Value | 9.15 |
| Total Debt to Enterprise Value | -0.0 |
| Debt to Equity | 0.0 |
| Revenue | $431 Thousand |
| Gross Profit | $431 Thousand |
| EBIT | -$1.05 Million |
| Net Income | -$2.02 Million |
| Profit Margin | -469.61% |
| Quarterly Earnings Growth (YoY) | +104.5% |
| Return on Equity | -4.23% |
| Return on Assets | -4.19% |
| Return on Invested Capital | -2.2% |
Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties.
